Knowledge Tree
Hirschfeld Oncology
Facts (15)
Sources
10 Breakthrough Research and Clinical Trials Shaping the ... honcology.com Dec 29, 2025 15 facts
claimHirschfeld Oncology participates in ClinicalTrials.gov networks and maintains research partnerships with MD Anderson Clinical Trials and Johns Hopkins cancer research.
claimHirschfeld Oncology utilizes advanced genetic testing and tumor evolution tracking technologies to monitor how a patient’s cancer responds to therapy in real-time.
claimHirschfeld Oncology uses liquid biopsies and Circulating Tumor DNA (ctDNA) guidance to enable real-time tumor tracking tailored to each patient's unique disease profile.
claimHirschfeld Oncology integrates patient advocacy into its pancreatic cancer treatment model by ensuring patients are fully informed and actively involved in their care decisions.
claimHirschfeld Oncology employs a multidisciplinary team consisting of physicians, nurses, surgeons, and researchers to treat pancreatic cancer.
claimDr. Azriel Hirschfeld serves as the lead oncologist and medical director at Hirschfeld Oncology, where he leads a multidisciplinary team focused on personalized cancer therapy.
claimHirschfeld Oncology's scientific research is supported by funding from the National Institutes of Health (NIH) and the Department of Defense.
claimHirschfeld Oncology focuses its research efforts on immunotherapy, tumor metabolism studies, and early detection methods.
claimHirschfeld Oncology customizes chemotherapy intensity for pancreatic cancer patients by evaluating performance status, age, and nutritional health, including the use of dose-reduced regimens for frail patients.
claimHirschfeld Oncology provides individualized treatment plans for patients by utilizing a multidisciplinary team that collaborates on care strategies.
claimHirschfeld Oncology utilizes molecular profiling to direct the use of targeted therapies, such as PARP inhibitors like Olaparib, for patients with specific genetic subgroups.
claimHirschfeld Oncology develops individualized treatment strategies that are tailored to each patient’s unique tumor profile and health status.
claimHirschfeld Oncology uses continuous data flow from tumor monitoring to inform precision modifications in treatment, aiming to improve effectiveness while minimizing unnecessary side effects.
claimHirschfeld Oncology enrolls patients in clinical trials to provide access to novel agents and combination regimens designed to overcome treatment resistance and target the tumor microenvironment.
claimHirschfeld Oncology incorporates off-label and emerging therapies into treatment plans when appropriate to improve patient quality of life.